Vivanza Biosciences Ltd.BSE: VIVANZA

Vivanza Biosciences Ltd. Press Release Nov 03 2025

· Issued by Vivanza Biosciences Ltd. via BSE India

Filed with BSE ·

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Pursuant to Regulations 29 & 30 of SEBI (LODR) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, November 11, 2025, at the Registered Office to consider and approve: (1) Unaudited Standalone & Consolidated Financial Results along with Limited Review Report for the quarter ended September 30, 2025; (2) To take note of the resignation of CS Siddhi Shah, Company Secretary & Compliance Officer w.e.f. September 26, 2025; (3) To consider appointment of CS Chaitra Arora (A78376) as Company Secretary & Compliance Officer; and (4) Any other business with permission of the Chair. The notice is available on the Company's website: https://vivanzabiosciences.com/announcement/. The trading window remains closed till 48 hours after declaration of the said results.

View Attachment

6ix hasn’t read this filing yet.

Vivanza Biosciences Ltd. on 6ix

Earlier from Vivanza Biosciences

Later from Vivanza Biosciences

All Vivanza Biosciences news releases